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ABSTRACT
HYDRODYNAMIC EFFECTS OF A CANNULA
IN A USP DISSOLUTION TESTING APPARATUS 2
by
Qianqian Liu
Dissolution testing is routinely used in the pharmaceutical industry to provide in vitro
drug release information for drug development and quality control purposes. The USP
Testing Apparatus 2 is the most common dissolution testing system for solid dosage
forms. Usually, sampling cannulas are used to take samples manually from the
dissolution medium. However, the inserted cannula can alter the normal fluid flow within
the vessel and produce different dissolution testing results.
The hydrodynamic effects introduced by a permanently inserted cannula in a USP
Dissolution Testing Apparatus 2 were evaluated by two approaches.

Firstly, the

dissolution tests were conducted with two dissolution systems, the testing system (with
cannula) and the standard system (without cannula), for nine different tablet positions
using non-disintegrating salicylic acid calibrator tablets. The dissolution profiles at each
tablet location in the two systems were compared using statistical tools. Secondly,
Particle Image Velocimetry (PIV) was used to obtain experimentally velocity vector
maps and velocity profiles in the vessel for the two systems and to quantify changes in
the velocities on selected horizontal iso-surfaces.
The results show that the system with the cannula produced higher dissolution
profiles than that without the cannula and that the magnitude of the difference between
dissolution profiles in the two systems depended on tablet location. However, in most
dissolution tests, the changes in dissolution profile due to the cannula were small enough
to satisfy the FDA criteria for similarity between dissolution profiles (f1 and f2 values).

PIV measurements showed slightly changes in the velocities of the fluid flow in
the vessel where the cannula was inserted. The most significant velocity changes were
observed closest to the cannula. However, generally the hydrodynamic effect generated
by the cannula did not appear to be particularly strong, which was consistent to
dissolution test results.
It can be concluded that the hydrodynamic effects generated by the inserted
cannula are real and observable. Such effects result in slightly modifications of the fluid
flow in the dissolution vessel and in detectable differences in the dissolution profiles,
which, although limited, can introduce variations in test results possibly leading to failure
of routine dissolution tests.
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CHAPTER 1
INTRODUCTION

1.1 Background
In the pharmaceutical industry, dissolution testing is routinely used to simulate adequate
in vivo drug release of oral solid dosage forms through in vivo/in vitro correlations
(IVIVC), as required by the Food and Drug Administration (FDA) and specified in
United States pharmacopoeia (USP). Dissolution testing has emerged as an essential tool
to guide and assess the design of new formulations, and as a quality control technique to
monitor lot-to-lot consistency of the drug products.
The USP Dissolution Testing Apparatus 2 is the most commonly and widely used
of all the dissolution testing devices listed in the USP (2012). It has been used in
pharmaceutical industry for decades since it was first officially introduced as a USP
method in the 1970s (Cohen et al., 1990). However, a review of the literature shows that
it is susceptible to errors and test failures (Cox and Furman, 1982; Cox et al., 1983;
Bocanegra et al., 1990; Moore et al., 1995; Qureshi and McGilveray, 1999; Qureshi and
Shabnam, 2001; Mauger et al., 2003), possibly associated to the extreme susceptibility of
this apparatus to small variation in its geometry and the location of the tablet during the
dissolution process (Bai and Armenante, 2009).
In recent years, a number of investigations have been conducted to determine the
hydrodynamics of the dissolution apparatus. Both experimental and computational
methods have been used, such as Laser Doppler Velocimetry (LDV), Particle Image
Velocimetry (PIV), Laser-Induced Fluorescence (LIF), and Computational Fluid
Dynamics (CFD) (Bocanegra et al., 1990; McCarthy et al., 2003, 2004; Kukura et al.,
1

2003, 2004; Baxter et al., 2005; Bai et al., 2007, 2011; Bai and Armenante, 2008, 2009).
These studies have indicated that the hydrodynamics of USP Dissolution Testing
Apparatus 2 can be responsible for some of the poor reproducibility and inconsistencies
of the dissolution results since the fluid flow in Apparatus 2 is highly nonhomogeneous.
This system can be expected to be associated with a complex hydrodynamics, resulting in
fluid velocities whose directions and intensities are highly dependent on the location
within the vessel, especially at the bottom of the vessel where the tablet is usually located
during dissolution testing (Bai et al., 2011).
Another source of variability during dissolution testing is associated with small
changes in the geometry of the system due to the fact that USP Apparatus 2 consists of a
symmetrical vessel with no baffles (Wang and Armenante, 2012). For example, a slightly
irregular inner shape of a glass dissolution vessel can produce very different dissolution
profiles that may result in test failures (Tanaka et al., 2005; Liddell et al., 2007). Also,
Bai and Armenante (2008) reported significant changes in velocity profiles and shear
rates when impeller location was placed 2 mm off center within the vessel through
Computational Fluid Dynamics (CFD) approach. Such small geometry changes can be
expected to affect the dissolution profile of a tablet located at the bottom of the vessel,
and were confirmed by Wang and Armenante (2012) using an experimental approach
(placing the paddle 8 mm off vessel’s center). External vibrations have also been shown
to introduce significant variability in the dissolution profiles (Gao et al., 2006; 2008).
Similarly, a sampling probe permanently inserted in the dissolution medium can
also changes the symmetry of the dissolution system and the hydrodynamics within the
vessel, hence possibly affecting the dissolution profile of the tablet (Wells, 1981; Savage

2

and Wells, 1982; Schatz et al., 2000; Bynum et al., 2001; Lu et al., 2003; Nie et al.,
2009). Even if the size of the sampling probe is small, it can still act as a small baffle in a
perfectly symmetrical system. The resulting loss of symmetry and the introduction of a
baffling effect can result in changes in velocity profile and shear rates, which in turn
could cause variations in dissolution testing results comparing to the system without such
a device (Wells, 1981; Savage and Wells, 1982; Cox et al., 1984).
Cannulas are among the simplest and most common sampling probes used in
Apparatus 2. A cannula consists of a thin tube attached to a syringe and used to take
samples from the dissolution medium manually. Cannulas vary in length from 4.75” (120
mm) to 15” (380 mm) and are made from either stainless steel or plastic materials such as
polyether ether ketone (PEEK) in order to prevent adsorption or interference with the
active ingredient of the drug. A cannula is usually mounted on perforated stopper that is
inserted in the vessel lid during manual sampling (to ensure that the sample is always
taken at the same liquid depth) and then rapidly removed after the sample is collected.
Sometimes a filter is mounted at the end of the sampling cannula. Although manual
sampling is labor intensiveness and susceptibility to operator’s error, it is still widely
used in pharmaceutical industry and auto-sampling requires validation with manual
sampling (USP 2012).
In order to simplify sample collection or to automate the sampling process, a
cannula can be permanently inserted in the medium in the dissolution vessel. In such a
case, the cannula can act as a small baffle and affect the system hydrodynamics and the
dissolution rate just like any other probe, as already mentioned above. Investigations
about the effect of sampling probes have been conducted in the past. Early studies by
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Wells (1981) and Savage and Wells (1982) pointed out that the use of sampling probes,
especially those larger in size, could result in appreciably faster dissolution rates than the
results obtained from the system absence of a fixed probe. Cox et al. (1984)
recommended using small cannulas without a filter mounted at the end to reduce
hydrodynamics effects. Other investigators have instead concluded that the presence of a
probe had a minimal or small effect on dissolution (Lu et al., 2003; Mirza et al., 2009;
Nie et al., 2009). However, in most of those studies the effect of an auto-sampling probe,
such as a fiber optic probe, was investigated. Recently, two studies on the effect of the
presence of a fiber optic sampling probe on dissolution have been conducted by our
group (Zhang et al, 2013; Wang et al., 2013). These studies have shown that even such a
probe can alter the system’s hydrodynamics significantly enough to result in small but
statistically differences in dissolution profiles. However, and except as noted above, no
well-defined, detailed studies with Apparatus 2 dissolution systems have been conducted
in which a cannula is permanently inserted in the medium.

1.2 Objectives of This Work
The overall objective of this research work was to quantify the hydrodynamic effects of a
cannula in a USP Dissolution Testing Apparatus 2. This goal was achieved here by using
two different methodologies, i.e., dissolution tests using non-disintegrating tablets
(salicylic acid calibrator tablets) and velocity measurements using Particle Image
Velocimetry (PIV).
In order to study solely the hydrodynamic changes introduced by the cannula and
its effect on the dissolution profiles, any other factors that could also affect the test results
should be eliminated. As shown in previous studies (Bai et al., 2009; Wang and
4

Armenante, 2012) on the USP Dissolution Apparatus 2, tablets placed at different
locations of the vessel’s bottom produced significant variations in flow velocities and
dissolution profiles. Therefore, in this study dissolution tests were conducted in the
presence and in the absence of the cannula using not only tablets dropped in the vessel as
recommended by the USP, but also using tablets fixed in place at 9 different positions at
the bottom of the USP Apparatus 2 dissolution vessels. Statistical tools, such as f1, f2
factor and Student’s t-values, were used to evaluate and compare the results from two
systems at the same tablet location.
Additionally, PIV studies were conducted in order to find the root cause of the
possible hydrodynamic effects introduced by the cannula on the dissolution profiles. PIV
was used to visualize and quantify the flow velocity field in the dissolution vessel under
different conditions. Then a comparison of the variations in flow field between the testing
system (with the cannula) and the standard system (without the cannula) was performed.
This approach also allowed a comparison to be made between changes in the dissolution
profiles and variations in the flow filed that could be attributed to the presence or absence
of the cannula.
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CHAPTER 2
EXPERIMENTAL APPARATUS, MATERIALS AND METHODS

2.1 Dissolution Tests
2.1.1 Dissolution Apparatus
A commercial USP Dissolution Testing Apparatus 2 (Distek 5100 Bathless Dissolution
Apparatus; Distek Inc., North Brunswick, NJ), as shown in Figure 2.1a, was used to
conduct all dissolution experiments. This equipment can accommodate seven standard
dissolution vessels consisting of unbaffled, cylindrical, hemisphere-bottomed transparent
glass vessels. Each vessel is provided with a lid with two openings for sampling during in
the experiments (Figure 2.1b). The agitation system consisted of a standard USP
Apparatus 2 two-paddle impeller mounted on a shaft and connected to the motor in the
Distek system rotating at 100 rpm.

(a)

(b)

Figure 2.1 (a) Distek 5100 Bathless Dissolution Apparatus (b) USP Dissolution Testing
Apparatus 2: paddle impeller and glass vessel.

6

The exact geometric dimensions of the impeller were measured with a caliper,
and were found to be as follows: shaft diameter, 9.52 mm; length of the top edge of the
blade, 74.10 mm; length of the bottom edge of the blade, 42.00 mm; height of the blade,
19.00 mm; and thickness of the blade, 4.00 mm. The impeller clearance off the vessel
bottom was 25 mm, as prescribed by the USP (2012). When the vessel was filled with
900 mL of dissolution media, the corresponding liquid height was 132.43 mm, measured
from the bottom of the vessel. The geometry of the system (vessel with 900 mL of
dissolution media and agitation system) is shown in Figure 2.2.
The cannula tested in this study was a bent polyether ether ketone (PEEK)
cannula purchased from Hanson. The cannula was 210 mm in length (from head mount to
the tail-end) with a 160-mm straight section and a 3.14-mm OD, as measured by the
caliper. As specified in the USP, samples, when taken with a cannula, should be taken
within a required zone in the dissolution medium, i.e., vertically midway between the top
edge of the impeller and the surface of the dissolution medium, and horizontally located
not less than 1 cm from the vessel wall. A stopper was used to ensure that the bottom of
the cannula was located in the sampling zone during dissolution tests, although here the
cannula was not used for manual sampling. The cannula with the stopper is shown in
Figure 2.3 and the detailed position of the cannula in the vessel is shown in Figure 2.4.
A spectrophotometer (Cole Parmer S2100UV+) was used to analyze the liquid
samples and get the UV absorption data.
A pH meter (Hanna Instruments HI221) was used to adjust the pH value of the
dissolution medium to 7.4 ± 0.05.
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Figure 2.2 (a) Front view of USP Dissolution Testing Apparatus 2 vessel.
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Figure 2.2 (b) Bottom view of USP Dissolution Testing Apparatus 2 vessel (Continued).

Figure 2.3 The cannula with the stopper.
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Figure 2.4 (a) Front view the dissolution testing vessel with the cannula.
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Figure 2.4 (b) Side view of the dissolution testing vessel with the cannula.
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Figure 2.4 (c) Top view of the dissolution testing vessel with the cannula.

2.1.2 Dissolution Test Materials
Non-disintegrating tablets, i.e., 300 mg salicylic acid calibrator tablets (USP lot
Q0D200), purchased from USP (Rockville, MD) were used in the dissolution testing
experiments. A very small amount of commercial acrylic glue was used to fix the tablet at
a particular position on the bottom of the dissolution vessel.
900 mL of de-aerated phosphate buffer constituted the dissolution medium. The
medium consisted of a 0.05 M monobasic potassium phosphate buffer to which sodium
hydroxide was added to reach a final pH value of 7.4 ± 0.05. The medium was de-aerated
before using it according to the degassing method developed by Moore (1996) following
the USP requirement (USP, 2012) (Figure 2.5). Accordingly, the medium was placed in a
carboy tank connected to a vacuum pump. Vacuum was applied for 30 minutes while all
other valves in the system were closed. This stock solution was used as needed (typically
in 900 mL aliquots per test).
12

Figure 2.5 Setup of de-aeration process for dissolution medium. (USP, 2008)

In this work, two 12 mL syringes and two stainless steel cannulas (2 mm OD)
were used to take samples manually from the dissolution systems. Disposable PVDF 0.45
µm filters were attached to the syringes to remove possible solid particles that could have
entered the liquid samples, as described in Section 2.1.3.
2.1.3 Dissolution Test Method
Each side-by-side experiment consisted of conducting dissolution tests in both the system
with the permanently inserted cannula and in the standard dissolution system without the
cannula. The agitation speed was always 100 rpm and the temperature was maintained at
37 oC throughout the dissolution experiment by the system’s temperature controller. Each
dissolution test for any tablet configuration was performed in triplicate.
Two approaches were used to expose the tablet to the dissolution medium during
the dissolution test. The first was the approach specified in the USP (2012). Accordingly,
the tablet was dropped in the vessel at the beginning of the experiment, the agitation (100
rpm) was started, and the first manual sample was immediately collected.

13

The second approach was slightly different from that recommended by the USP in
that the tablets were glued at the same predefined location on the vessel bottom in both
systems with a very small head of commercial glue prior to the beginning of the
experiment. Nine tablet positions were investigated in the non-symmetrical testing
system with the cannula, as shown in Figure 2.6(a). Tablets in Position O were placed in
the center of the vessel bottom. Positions A1, B1, C1 and D1 were all on the same inner
circle 10° off-center from the vessel vertical centerline while Position A2, B2, C2 and D2
were all on the same outer circle 20° off-center from the vessel vertical centerline (Figure
2.6(b)). These angles originated from the center of the sphere comprising the
hemispherical vessel bottom, and were measured starting from the vertical centerline to
the point of interest, (e.g., the angle would be zero for the central point below the
impeller). On each circle, the positions were spaced 90° apart from each other. In the
standard system, the same nine tablet positions were selected in order to make pairs with
that from the testing system, although only three positions would be sufficient in the
symmetrical standard system.

Figure 2.6 (a) Top view of the bottom of the dissolution vessel with nine different tablet
positions in testing system.
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(b)
Figure 2.6 (b) The front view of the dissolution vessel with three different tablet
positions (0°, 10°, 20°) in standard system (Continued).
All key geometrical measurements were checked before each experiment
(impeller clearance, impeller position, etc.). Once the vessels with the attached tablets
were setup properly in the Distek system, 900 mL de-aerated dissolution medium,
previously preheated to 37.5 oC, was gently poured into each of the two vessels in order
to minimize gas introduction and prevent the rapid initial dissolution of the tablet. The
agitation was turned on immediately after the addition of the dissolution medium, the
cannula was inserted to the predefined place in the testing system, and a stopwatch was
started simultaneously.
Sample collection was always manual (i.e., it did not rely on the use of the
cannula) and was identical for all experiments. The first pair of samples was taken
immediately after starting the agitation. These samples concentrations were defined as the
zero-time-point concentration. The time interval between subsequent samples was 5

15

minutes. Each experiment lasted 45 min, which meant that ten samples were taken for
each system.
Each 10-mL aliquot sample was taken manually from the dissolution medium
using a 12-mL syringe and a stainless steel cannula (2 mm OD). The volume of medium
removed by sampling was not replaced, according to the USP procedure (USP, 2012).
The sampling position was vertically midway between the top edge of the impeller and
the surface of the dissolution medium and horizontally located 13.22 mm from the vessel
wall, that is, within the USP specified sampling zone. After the sample was collected, the
stainless steel cannula was removed immediately and then a disposable PVDF 0.45 µm
filter was mounted on the syringe to remove possible solid particles that could have
entered the sample prior the sample analysis. The initial 2 mL of each sample was
discarded, and the remaining sample was transferred to a vial for further analysis.
Analysis of samples was carried out using 1-cm quartz cell placed in a UV
spectrophotometer (Cole Parmer S2100UV+; Cole Parmer, Vernon Hills, Illinois)
measuring absorbance at 296 nm, the USP prescribed wavelength for salicylic acid.
Before putting the sample solution into the quartz cell to analyze, the cell was rinsed
three times with the same solution. The absorbance reading were converted to the
concentration of dissolved salicylic acid using a previously obtained absorbance-vs.concentration calibration curve (R2=0.9998). This calibration curve was obtained by
preparing reference standard solutions of salicylic acid and diluting them to obtain
solutions of different known concentrations. The absorbance of these solutions generated
an absorbance versus concentration standard curve.

16

Note that for the salicylic acid tablet, for most experiments, samples collected
after t=25 minutes needed to be diluted so that their UV absorbance was in the
appropriate range. These samples were diluted into one-half with dissolution medium.
Additional details of the operating conditions are summarized in Table 2.1.
Table 2.1 Operating Conditions for Dissolution Experiments with Calibrated Salicylic
Acid Tablet
Salicylic Acid Tablet

Operating Conditions

Dose

300 mg

Medium

900 ml de-aerated, pH=7.4 buffer (KH2PO4)

Temperature

37 oC

Agitation Speed

100 rpm

Filter

PVDF 0.45 µm

UV Wavelength (UV Spectroscopy)

296 nm

Time

5 min sampling interval; 45 min total

Sample Volume

10 ml

Sample Replacement

No

2.1.4 Dissolution Test Data Analysis
The dissolution profiles are presented in terms of drug release fraction (mD/mT), that is,
the mass of released drug in the dissolution medium at any time t out of the total mass of
drug initially in the tablet, as a function of time. The absorbance data obtained from the
UV spectrophotometer was first converted to salicylic acid concentration at given time,
(Cj, in mg/mL), and then transformed into drug mass release fraction (mD/mT) using the
following equations, in order to account for the drug mass removed with each sample:
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mD ( t1 ) C1
for j 1
=
=
mT
C*

mD ( t j ) C j 
∆V  ∆V j −1
=
−
−
+
1
1
j
(
)
∑ Ck
mT
C * 
V  V k =1

(2.1)

for 2 ≤ j ≤ n

(2.2)

where j is an index identifying the number of sampling (j=1, 2, … 10), mD(tj) is the mass
of released salicylic acid at time tj, mT is the total mass of salicylic acid initially in the
tablet, Cj is the dissolved salicylic acid concentration in the jth sampling at time tj, C* is
the concentration of salicylic acid when the tablet is fully dissolved in 900 mL dissolution
medium, ΔV is each sampling volume (10 mL) and V is the initial volume of dissolution
medium (900 mL). At the beginning of the experiment (t=t1=0 minutes) the first sample
was taken immediately (j=1) resulting in an initial concentration C1, and the 10th sample
was taken at t10=45 minutes (j=10).
The dissolution profiles obtained with tablets at each position in the testing
system were compared to those from its paired standard system in order to determine
whether these dissolution curves were statistically similar or not. Two approaches were
used.

The first approach was that recommended by the FDA to quantify the

similarity/difference of two dissolution profiles. This approach consists of a modelindependent method based on the difference factor (f1) and similarity factor (f2) proposed
by Moore and Flanner (1996):
n

f1
=

∑R
t =1

t

− Tt

n

∑R
t =1

× 100

t
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(2.3)

1 n
f=
50log
{[1
+
(
)∑ (Rt − Tt )2 ]−0.5 × 100}
2
10
n t =1

(2.4)

where Rt is the reference assay at time t (i.e., the results from the standard system), Τt is
the test assay at the same time (i.e., the paired results from the testing system), and n is
the number of time points. The difference factor (f1) calculates the percent (%) difference
between the two curves at each time point and measures the relative error between two
curves. The higher the f1 (which can be in the range of 0 to 100), the higher the average
difference between reference and test curves is (Moore and Flanner, 1996). The similarity
factor (f2) is a logarithmic reciprocal square root transformation of the sum-squared error
of differences between the reference and test profiles over all time points (which can be
in the range -α to 100). The higher the f2, the lower the average difference between
reference and test curves is (Costa and Lobo, 2001). Public standards have been set by
FDA for f1 and f2 factors. Accordingly, statistical similarity between the two curves being
compared requires that 0<f1<15 or 50<f2<100 (FDA, 1997).
The second approach was the standard Student’s t-test based on the analysis of
variance and the calculation of the probability that the two sets of data came from the
same underlying population (null hypothesis) using the following equations (Lapin,
1975):

T -value =

X D − µ0
SD n '

(2.5)

(2.6)
DF= n '− 1
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����
where 𝑋
𝐷 is the sample mean (here is the average differences between two curves), 𝜇0 is

the population mean (in this case the constant from which to test whether the average of

the difference is different, i.e., 𝜇0 =0 here), SD is the sample standard deviation (here is the
standard deviation of the differences between curves), DF is the degree of freedom (here

the initial data point at t=0 was not used) and n’ is the number of samples excluding the
first one (Schatz et al., 2001). The probability that the null hypothesis is correct can be
obtained from the T-value in Equation (2.5) using the experimental data as input and with
the table of values from Student's t-distribution (Lapin, 1975). The significance level was
chosen here to be 0.05, i.e., if the probability obtained was smaller than 0.05, the null
hypothesis was rejected and the two groups of data were considered to be statistically
different.

2.2 Particle Image Velocimetry (PIV)
2.2.1 Particle Image Velocimetry (PIV) System
A Dantec FlowMap 1500 2D Particle Image Velocimetry (PIV) apparatus (Dantec
Dynamics A/S, Tonsbakken 16 – 18, DK – 2740 Skovlunde, Denmark) was used to
determine the velocity flow field and turbulence intensity inside the dissolution vessel in
both testing system and standard system. The PIV system comprised a double pulsed 120
mJ Nd-Yag laser (New Wave Research model Solo 120 15 Hz, Fremont, CA, USA), a
digital camera (Dantec Dynamics HiSense PIV/PLIF camera model C4742-53-12NRB)
with a charge coupled device (CCD) chip, a synchronizer (LASERPULSE Synchronizer,
TSI model 610034) and the software (FlowManager 4.71) installed in a computer (DELL
Precision WorkStation 530), as shown in Figure 2.7.
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Figure 2.7 Schematic of laboratory PIV experimental set-up.

In the PIV experiment, the dissolution vessel was placed in an external Plexiglas
square tank filled with water in order to minimize refractive effects at the curved surface
of the vessel wall. Black plastic shaft and impeller were specially used to minimize the
reflection of the laser light impinging on them. The agitation was kept 100 rpm and
provided by an electric motor connected to an external controller. The water (900 mL) in
the dissolution vessel was seeded with trace amounts of 10 μm silver-coated hollow
borosilicate glass spheres (Dantec Measurement Technology USA, Mahwah, NJ, USA)
which were used to follow the fluid flow and scatter the laser light for fluid velocity
measurements.
The light source of the PIV system came from the Class IV Nd-Yag laser,
consisting of two infrared laser heads combined in a single package with a second
harmonic generator and two discrete power supplies and emitting 532 nm wavelengths
light. Two pulsed infrared laser beams were produced by the laser and passed through an
optical arrangement of lenses to generate a laser light sheet. When the laser light sheet
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was shot through the dissolution vessel with seed particles in the water, the light scattered
by these particles was captured by the CCD camera which was installed next to the tank
at a 90º orientation with respect to the laser light sheet. A light filter is fitted in front of
the camera lens to remove visible light and any incident laser light from reflection. The
camera and the laser were connected to the synchronizer which was then in turn
connected to the computer running the FlowManager 4.71 software for test control and
data analysis. Pairs of digitized images of illuminated particles in the dissolution vessel
from the camera were subdivided into small subsections called interrogation areas via the
software and then were analyzed using cross-correlation to determine the spatial x- and ydisplacement that maximized the cross-correlation function for that interrogation area.
The resulting displacement vector obtained by dividing the x- and y- displacements by
the time interval was taken as the fluid velocity in that interrogation area.
2.2.2 PIV Method
In the PIV experiment, the velocity profiles on only one-half section of the vessel could
be measured due to the shaft blocking the laser light sheet. In the standard system, only
one lengthwise cross-section of the vessel was studies, since the standard system (without
the cannula) was symmetrical. In the system with the cannula, the velocity profiles were
measured on four lengthwise cross-sections, 90° apart from each other, since this system
was non-symmetrical because of the presence of the cannula in the medium. Using the
tablet position numbering mentioned before (Figure 2.6 (a)), the four sections were
named Section A, Section B, Section C and Section D, as shown in Figure 2.8. However,
when studying Section A, the cannula could block the laser light sheet. Therefore, two
additional PIV measurements were conducted in order to show the velocities on vertical
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planes just before or just behind the cannula: Section A-Front was the vertical section
where the laser sheet was just in front of the cannula (by about 2 mm) while Section ABack, where the laser sheet was just behind cannula (by about 2 mm), as shown in Figure
2.8 and Figure 2.9. The PIV measurements were conducted three times for all sections,
except the Section A-Front and Section A-Back.
A PIV measurement consisted of taking a pairs of images at a time interval of 1
ms. In each PIV test, 300 image pairs in total were captured by the CCD camera, at a
time interval of 1000 ms between each pair. Then, image masks were defined and applied
to all images to reject the impeller and shaft regions, and the obscured regions not
illuminated by the laser and all external regions, in order to reduce the error in cross
correlation. Each image was divided in interrogation areas 16 pixels x 16 pixels. Crosscorrelation was employed on each interrogation areas in each image pair to determine the
most likely velocity vector that best resulted in the first interrogation area being
superimposed on the second. That velocity vector was taken to be the velocity projection
of the fluid velocity on that vertical section. For each interrogation area, the final velocity
vector on the vertical section was taken to be the statistical average of the 300 pairs
image pairs. By applying this approach to each area the velocity profile on the entire
section was obtained. The profile then went through moving-range validation and average
filter to obtain the final velocity vector map for further analysis. (FlowMap PIV
Installation & User’s guide, 2000)
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Section A

Section B

Section C

Section D

Figure 2.8 Schematic of the sections (in grey) studied using PIV.
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Section A-Front

Section A-Back

Figure 2.8 Schematic of the sections (in grey) studied using PIV (Continued).

Section A

Section A-Front

Section A-Back

Figure 2.9 Schematic of the top views in Section A, Section A-Front and Section ABack.
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Figure 2.10 Eleven iso-surfaces chosen for PIV measurements.

The liquid velocity at any point in the vessel has three components: radial
velocity, acting in a direction perpendicular to the shaft of the impeller; axial velocity,
acting in a direction parallel with the shaft; and tangential velocity, acting in a direction
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tangent to a circular path around the shaft. In this 2-D PIV study, only the axial and radial
velocities were investigated.
To fully quantify the fluid flow in the dissolution vessel, eleven iso-surfaces at
different vertical (z) positions were selected along the height of the vessel, as shown in
Figure 2.10. The bottom of the vessel was taken as the iso-surface at z = 0 mm. Four isosurfaces were chosen below the impeller (z = 5 mm, 10 mm, 15 mm and 20 mm). Three
were chosen in the impeller region: the bottom edge of the impeller, i.e., z = 25mm, the
middle of the impeller, i.e., z = 35mm, and the top edge of the impeller, i.e., z = 44mm.
Four were chosen above the impeller: z = 50 mm, z = 75 mm, z = 100 mm and z = 125
mm. The average radial and axial velocities and standard deviation for each data point on
each iso-surface were extracted, plotted and analyzed.
In order to determine the reproducibility of the PIV measurement and to
determine the suitability of the instrument to detect differences between velocities in the
standard system and in the testing system, six identical experiments with the standard
system alone were conducted. The average standard deviations in those three regions, i.e.,
below the impeller, around the impeller and above the impeller, were calculated and
presented.
Sums of squared deviations were calculated to compare the velocity profiles on
the four sections of the testing system to those of the standard system.

𝑆=�

(𝑈 − 𝑈0 )2
𝑈𝑡𝑖𝑝 2
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(2.7)

where U is the velocity of the testing system and U0 is the corresponding velocity of the
standard system at the same point. By summing up all squared deviations in each of the
three regions, i.e., below the impeller, around the impeller and above the impeller, as well
as in the whole section, the hydrodynamic effect generated by the cannula could be
identified and quantified.
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CHAPTER 3
RESULTS
As mentioned in Chapter 2, the objective of this project was to quantify the
hydrodynamic effects introduced by the presence of a cannula in a USP Dissolution
Testing Apparatus 2 by the dissolution test and PIV measurement. The dissolution
profiles obtained in the two systems (standard system and testing system) were compared
by plotting mD/mT (fractional drug release) against time (min) and evaluating the
difference using statistical tools. The velocity profiles obtained from the PIV
measurements for the two systems were also compared by visualizing the flow velocity
vectors and quantitatively analyzing the velocities on eleven iso-surfaces.

3.1 Results of the Dissolution Tests
In order to determine the effect of the cannula in dissolution tests, experimental data
obtained from two systems, with and without cannula, were examined for all nine
different tablet positions. The averages of triplicate experimental dissolution profiles at
each tablet position are presented in terms of mD/mT against time together with the
standard deviations of three replicates (Figure 3.2 through Figure 3.10). The results of the
dissolution test following the USP procedure is shown in Figure 3.11. The difference
factor (f1), similarity factor (f2) and probability associated with the Students’ t-test (P(ttest)) were calculated for the averages of triplicate experimental profiles at each tablet
position, and are presented in Table 3.2.
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3.1.1 Calibration Results for Salicylic Acid Tablets
Calibration was performed following the method described in Section 2.1.3. A series of
salicylic acid solution with known concentration were detected by the UV
spectrophotometer at the wavelength 296 nm. This process was initially performed twice
to establish the conversion from UV absorbance to salicylic acid concentration, and
repeated every 3 months, without showing significant change. The results are presented
in Table 3.1 and Figure 3.1 for two sets of calibration experiments.
Table 3.1 Calibration Data for Prednisone Tablets
Concentration

Average
Absorbance 1

Absorbance 2

(mg/ml)

Absorbance

0.00000

0.036

0.036

0.036

0.00234

0.090

0.092

0.091

0.00469

0.145

0.145

0.145

0.00938

0.252

0.253

0.2525

0.01875

0.467

0.470

0.4685

0.03750

0.895

0.899

0.897

0.07500

1.711

1.717

1.714

The difference between the two set of absorbance data was minor, and the R2
value of the regression was 0.9998. Therefore, a linear relation between UV absorbance
and concentration was confirmed in this concentration range (0 – 0.075 mg/mL). The
equation displayed in Figure 3.1 was used to obtain the sample concentration from
absorbance data.
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Calibration curve for Salicylic acid
0.08

y = 0.0446x - 0.0019
R² = 0.9998

Concentration (mg/mL)

0.07
0.06
0.05
0.04
0.03
0.02
0.01
0
-0.01 0

0.2

0.4

0.6
0.8
1
1.2
UV Absorbance (at 296 nm)

1.4

1.6

1.8

Figure 3.1 Calibration curve and regression for Salicylic Acid tablets.

3.1.2 Dissolution Profiles for Centered Tablets (Position O)
The dissolution profiles for the tablets in the center position are presented in Figure 3.2.
This figure shows that the difference between the dissolution profiles for the testing
system (with cannula) and the standard system (without cannula) is that at all times the
average mass percentage of drug dissolved in the testing system was higher than in the
standard system. Each individual paired experiment replicate also showed this difference
(results are not shown here). The average standard deviations for the drug release mass
ratios (mD/mT) in Figure 3.2 were 1.08% and 1.54% for the dissolution profiles with and
without cannula, respectively. The value of paired Student’s t-test, i.e., the probability
that the dissolution profiles came from the same population, was 0.000209 (Table 3.2),
which was much lower than the significance level of 0.05. On the other hand, the values
of f1 factor and f2 factor, quantifying the significance of similarity/difference of two
dissolution profiles, were 12.25, 86.17, respectively, which were both within the FDA
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required range (0<f1<15 and 50<f2<100). Although the value of f1 factor (12.25) was not
too distant from the upper limit f1 (15), those values were considered to be acceptable.
Table 3.2. Average Values of P(t-test), f1 and f2 for Dissolution Tests at Each Tablet
Position
Tablet Position
Centered

P (t-test)

f1

f2

O

0.000209

12.25

86.17

A1

0.000290

17.14

74.81

B1

0.001038

3.03

96.93

C1

0.000129

12.03

83.42

D1

0.005908

4.37

92.97

A2

0.000313

6.81

88.72

B2

0.002889

1.64

98.55

C2

0.000042

1.42

99.16

D2

0.021561

2.84

94.69

0.000082

6.87

90.89

10° off-center

20° off-center

Dropped Tablets (USP Procedure)
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Figure 3.2 Dissolution profiles for experiments with tablets in Position O in the presence
and absence of the cannula.

3.1.3 Dissolution Profiles for 10° Off-Center Tablets (Positions A1, B1, C1, and D1)
The results for the tablet on the 10° off-center circle positions are shown in Figure 3.3
through Figure 3.6, respectively, and the corresponding statistics are presented in Table
3.2. The average standard deviations for the drug release mass ratios (mD/mT) on the 10°
circle positions were 1.12% and 1.44% for the dissolution profiles in the two systems
with and without cannula, respectively. The values of Student’s t-test were all much
lower than the significant level 0.05 for all 10° off-center tablet positions.
Compared to the dissolution profiles for tablets in the center of the vessel bottom
(Position O), the drug release fractions (mD/mT) for tablets on this circle were always
much higher. For example, at t = 45 min, mD/mT was typically about 27-33% for the 10°
off-center tablets whereas it was only about 22-24% for the centered tablets. These results
were in agreement with previously reported work (Wang and Armenante, 2012).
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For all the four positions on 10° off-center circle, the tablets in the system with
the cannula generated higher dissolution profiles than those in the standard system
without cannula. However, the intensities of the differences between the profiles from
two systems were different depending on the tablet locations. The tablet position that
produced the most different dissolution profiles on 10° circle was Position A1, which was
the closest to the cannula. The calculation of difference factor f1, similarity factor f2 and
Student’s t-test confirmed this observation: f1 had the largest value of all tablets positions
(17.14), f2 the smallest (74.81) and P(t-test) value was much less 0.05. In fact, Position
A1 was the only case for which f1>15, resulting in a test failure.
The next most significant difference between profiles was at Position C1. Tablets
in Position B1 and Position D1 were much lesser affected by the presence of the cannula,
as indicated by the smaller value for f1 (3.03, 4.37) and larger value for f2 (96.93, 92.97)
for this case compared to other tablet positions (Table 3.2). However, the Student’s t-test
value was still very small (0.001038, 0.005908) for Position B1 and Position D1,
indicating that the two curves were still statistically different (P(t-test)<0.05).
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Figure 3.3 Dissolution profiles for experiments with tablets in Position A1 in the
presence and absence of the cannula.
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Figure 3.4 Dissolution profiles for experiments with tablets in Position C1 in the
presence and absence of the cannula.
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Figure 3.5 Dissolution profiles for experiments with tablets in Position D1 in the
presence and absence of the cannula.
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Figure 3.6 Dissolution profiles for experiments with tablets in Position B1 in the
presence and absence of the cannula.
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3.1.4 Dissolution Profiles for 20° Off-Center Tablets (Positions A2, B2, C2, and D2)
The results for the tablet on the 20° off-center circle positions are presented in Figure 3.7
through Figure 3.10 and the corresponding statistics are shown in Table 3.2. The average
standard deviations for drug release mass ratios (mD/mT) in these figures were 1.26% and
1.27% for the dissolution profiles of the two systems with and without cannula,
respectively. The differences between the profiles for the systems on the 20° off-center
circle were less evident. In Position B2, Position C2 and Position D2 the mD/mT profiles
for the testing system were nearly identical or even below those for the standard system.
However, their values of t-test were still lower than the significance level of 0.05,
indicating that the two profiles were still statistically different. Only for Position A2 the
difference between the dissolution profiles for the two systems, was noticeable, although
only to a limited extent. For all positions in the 20° off-center circle, the f1 and f2 values
were in the appropriate range to pass the dissolution test, even for the Position A2 (f1
=6.81, f2 =88.72).
The dissolution profiles of tablets on the outer circle (20° off-center circle) were
always higher comparing to those on the inner circle (10° off-center circle), as previously
reported (Wang and Armenante, 2012). The results for tablets on two circles show some
similarities. Tablets nearest to the cannula (Positions A1 and A2) produced higher
differences between dissolution profiles with and without the cannula. However, in all
cases, the effect of the cannula was more pronounced when the tablets were on the inner
circle than when they were on the outer circle.
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Figure 3.7 Dissolution profiles for experiments with tablets in Position A2 in the
presence and absence of the cannula.
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Figure 3.8 Dissolution profiles for experiments with tablets in Position B2 in the
presence and absence of the cannula.
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Figure 3.9 Dissolution profiles for experiments with tablets in Position C2 in the
presence and absence of the cannula.
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Figure 3.10 Dissolution profiles for experiments with tablets in Position D2 in the
presence and absence of the cannula.
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3.1.5 Dissolution Profiles for the Tablets using USP Dissolution Procedure
According to the USP (2012), in the standard dissolution test the tablet is dropped into
the vessel after the medium had been added to the vessel and heated to 37ºC. The results
for the tablets using the USP dissolution procedure are shown in Figure 3.11, and the
corresponding statistics are shown in Table 3.2. The average standard deviations for the
drug release mass ratios (mD/mT) were 0.36% and 1.04% for dissolution profiles in the
standard system and the testing system, respectively. The dissolution profile obtained
from the testing system was slightly higher than that obtained from the standard system.
The value of the Student’s t-test (0.0000816) was much smaller than the significance
level (0.05). The values of f1 and f2 factors were 6.87, 90.89 respectively, which were
both within the FDA required range (0< f1 <15 and 50 < f2 <100).
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Figure 3.11 Dissolution profiles for experiments with tablets using USP Procedure in the
presence and absence of the cannula.
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3.2 Results of PIV Measurement
3.2.1 Velocity Vectors
The velocity vectors maps of the two systems are shown in Figure 3.12 and Figure 3.13.
In order to shown the entire velocities vector in Section A, two other tests (Section AFront, i.e., the laser sheet was in front of the cannula, and Section A-Back, i.e., the laser
was behind the cannula) were conducted and also presented in Figure 3.13. The vectors in
each of the images were scaled according to their magnitudes using the same scale factor.
The vectors were color-coded in order of increasing velocity magnitude. The vectors with
the lowest velocities were plotted in dark blue, followed by light blue, green, yellow,
orange and red, which represented the highest velocities.
The overall flow patterns that emerged from the vector maps were found to be
similar, as shown in Figure 3.12 and Figure 3.13. A big but weak recirculation loop
dominated by the axial velocity component generated by the impeller rotation can be
observed in the upper region of the vessel. Near the vessel wall (R/R0> ~0.7) this flow
was directed upwards, while in the middle inner core region above the impeller (~0.3 <
R/R0< ~0.7), the flow was directed downwards. In the innermost core region (R/R0<
~0.3), the flow is characterized by very low axial and radial velocities. The fluid region
around the impeller was dominated by the impeller rotation (Bai et al., 2007). The axial
and radial velocities changed significantly in this region. The flow in the region below
the impeller is the most important and complex for this work. All test sections show that
the flow in this region was very weak, especially the inner region just below the shaft at
the center of the vessel bottom. In this region, there was another recirculation loop
formed by the downwards flow produced by the agitation of the impeller and the vessel
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wall. This vertical recirculation loop was not able to penetrate the weak inner core region.
The flow patterns in the standard system are in agreement with those obtained in previous
studies (Bai et. al., 2007, Bai et al., 2009).
Despite the similarity between figures, two major differences could be observed.
Firstly, in almost all sections in the system with the cannula the recirculation loop above
the impeller became more intense, especially in the middle inner core region. The most
significant effect was on Section A (Back), followed by Section B and Section C, and this
effect seemed to disappear in Section D. This makes intuitive sense, in that the intensity
of the disturbances introduced by the cannula extends downstream of the cannula but
with decreasing intensity. Secondly, the velocities below the shaft, which is the most
important region in the vessel since this is where the tablets usually stay in practice, were
slightly stronger in Section A, Section A-Front and Section A-Back than in any other
sections, where larger radial velocities could be found especially near the center of the
vessel bottom. By contrast, in Section B, Section C and Section D, the velocities
remained nearly the same as those in the standard system, or even slightly smaller.
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Figure 3.12 PIV velocity vectors map for the standard system (velocities are in m/s).

Section A

Section A-Front

Section A-Back

Figure 3.13 PIV velocity vectors maps for all four sections in the testing system with
cannula (velocities are in m/s).
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Section B

Section C

Section D

Figure 3.13 PIV velocity vectors maps for all four sections in the testing system with
cannula (velocities are in m/s) (Continued).

3.2.2 Velocity Profiles on Iso-Surfaces
Figures 3.14 through 3.19 show, respectively, the radial and axial velocity profiles on
eleven iso-surfaces. In these figures, the ordinates represent the normalized fluid velocity
U/Utip (scaled by the impeller tip speed, Utip=0.388 m/s) and the abscissas represent the
normalized radial position R/R0 (scaled using the vessel radius, R0=50.08 mm). The
centrifugal radial velocity and the upwards axial velocity were defined as positive
velocities. It should be remarked that the scales in these figures are different.
3.2.2.1 Reproducibility of PIV Measurements. The average standard deviations in the
three regions examined here, i.e., below the impeller, around the impeller and above the
impeller, are presented in Table 3.3. The PIV measurements were found to be very
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reproducible in the regions below and above the impeller, while a slightly larger standard
deviation was found for the velocities around the impeller, because the velocities in this
region were affected by the presence of the impeller. Therefore, these velocities were
larger and more turbulent, causing more variability in the velocity data.
Table 3.3 Average Standard Deviations of PIV Measurements in Three Regions for the
Standard System
Region

Iso-Surfaces

Average Standard
Deviation

Below the Impeller

Z=5 mm, 10 mm, 15 mm, 20 mm

0.003890

Around the Impeller

Z=44 mm, 35 mm, 25 mm

0.006907

Above the Impeller

Z=50 mm, 75 mm, 100 mm, 125 mm

0.003111

Overall Average

0.004429

3.2.2.2 Velocity Profiles below the Impeller. Figure 3.14 and 3.15 show, respectively,
the average radial and axial velocity profiles and the standard deviation for each data
point on iso-surfaces below the impeller, i.e., Z=5 mm, 10 mm, 15 mm and 20 mm.
In general, the differences between the velocities in this region were small in
absolute value. The largest differences in radial velocities were found in the weak
velocity zone blow the shaft, i.e., R/R0< 0.2 for all four iso-surfaces. The most significant
velocity differences were found in Section A. Slightly higher axial velocities in Section A
were also observed in a smaller zone below the shaft, i.e., R/R0<0.1 for all four isosurfaces. This is consistent with velocity vector maps in Section 3.2.1.
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Figure 3.14 PIV measurements for radial velocities on different iso-surfaces below the
impeller.
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Figure 3.14 PIV measurements for radial velocities on different iso-surfaces below the
impeller (Continued).
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Figure 3.15 PIV measurements for axial velocities on different iso-surfaces below the
impeller.
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Figure 3.15 PIV measurements for axial velocities on different iso-surfaces below the
impeller (Continued).

3.2.2.3 Velocity Profiles around the Impeller. Figure 3.16 and 3.17 show, respectively,
the average radial and axial velocity profiles and standard deviation for each data point
on the iso-surfaces around the impeller, i.e., Z=25 mm, 35 mm and 44 mm.
As shown in these figures, a larger average standard deviation in this region was
obtained, which was agreement with the results of reproducibility for standard system in
this region (Table 3.3). Although the differences between each section were found much
larger, most data points were within the error range indicated by the error bars. However,
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several differences cannot be attributed to experimental error. On iso-surface Z=35 mm,
where the transition between two recirculation loop occurred, all sections showed
different flow velocities compared to the standard system, indicating that the flows were
stronger in this zone. On iso-surface Z=44 mm, the radial velocity in Section A was much
higher than for other sections in the zone near the impeller (~0.7<R/R0<~ 0.8).
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Figure 3.16 PIV measurements for radial velocities on different iso-surfaces around the
impeller.
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Figure 3.16 PIV measurements for radial velocities on different iso-surfaces around the
impeller (Continued).
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Figure 3.17 PIV measurements for axial velocities on different iso-surfaces around the
impeller.
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Figure 3.17 PIV measurements for axial velocities on different iso-surfaces around the
impeller (Continued).

3.2.2.4 Velocity Profiles above the Impeller. Figure 3.18 and 3.19 show, respectively,
the average radial and axial velocity profiles and standard deviation for each data point
on the iso-surfaces above the impeller, i.e., Z=50 mm, 75 mm, 100 mm, and 125 mm. In
section A, just part of the velocity profiles were shown in the figures, since the laser sheet
was blocked by the cannula. The differences in velocities profiles between different
systems can be easily observed in this region, specifically, in the area where the cannula
was located, i.e., for ~0.7<R/R0<~0.8 and in the downward recirculation zone, i.e., for
~0.3< R/R0<~0.5. In the region where ~0.7<R/R0<~0.8, the radial velocities in Section A
were much higher than those in other sections on all iso-surfaces. The largest differences
in axial velocities were in the region ~0.3< R/R0<~0.5 where all the testing sections
produced velocity profiles higher than those in in standard system. Overall, in Section A
the impact of the cannula was most pronounced. Also the impact of the cannula
continued in the region downstream of cannula, i.e., Section B, Section C, as well as
Section D.
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Figure 3.18 PIV measurements for radial velocities on different iso-surfaces around the
impeller.

52

0.1

Z = 125 mm

Uradal/Utip

0.05
0
0

0.2

0.4

0.6

0.8

1

-0.05
-0.1

R/R0
Standard

Section A

Section B

Section C

Section D

Figure 3.18 PIV measurements for radial velocities on different iso-surfaces around the
impeller (Continued).
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Figure 3.19 PIV measurements for axial velocities on different iso-surfaces around the
impeller.
53

0.1

Z = 100 mm

Uaxial/Utip

0.05
0
0

0.2

0.4

0.6

0.8

1

-0.05
-0.1

R/R0
Standard

0.1

Section B

Section C

Section D

Z = 125 mm

0.05

Uaxial/Utip

Section A

0
0

0.2

0.4

0.6

0.8

1

-0.05
-0.1

R/R0
Standard

Section A

Section B

Section C

Section D

Figure 3.19 PIV measurements for axial velocities on different iso-surfaces around the
impeller (Continued).

3.2.3 Sums of Squared Deviations of the Velocity Profiles
The sum of squared deviation (S value) was calculated for each of the three regions, as
described in Section 2.2.2. The results are shown in Table 3.4.
Overall, the velocities in Section A had largest total deviations compared to those
in the standard system than the other four sections in the system. This was followed by
Section C and Section B. In the region above the impeller, the impact of the cannula was
most pronounced, and Section A, Section B and Section C produced the similar
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deviations and much higher than Section D. The velocities around the impeller didn’t
show the significant effect on the presence of the cannula, considering the highest
standard deviation (0.006907) in all three regions in the reproducibility test. Section A
also was where largest difference can be found in the region below the impeller. In this
region, Section B, Section C and Section D produced similar but a lower S value,
indicating the effect of cannula was not significant in these sections.
Table 3.4 Sums of Squared Deviations
Section

Section A Section B Section C Section D

Below the Impeller

0.007977

0.002676

0.002578

0.002769

Around the Impeller

0.005403

0.003755

0.005377

0.001062

Above the Impeller

0.015841

0.012758

0.014871

0.006614

Total

0.029221

0.019189

0.022826

0.010445
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CHAPTER 4
DISCUSSION

4.1 Dissolution Tests
In this work, the results of the dissolution experiments show that the dissolution profiles
for the systems with cannulas tend to be higher than those in the standard systems,
without cannulas irrespective of tablet position, with the exception of the tablet Position
D2. These differences were slightly but observable from the averages of triplicated paired
dissolution profiles (as reported in Figure 3.2 through Figure 3.10, with the exception of
Figure 3.10), and ranged from 4.5% to 0.2%, depending on tablet location. Most
differences between the dissolution profiles might not be attributed to data scatter since
the average standard deviation of triplicate experiments was usually small (the standard
system 1.38% and the testing system 1.18%). The Student’s t-test values for all runs were
lower than the 0.05 significance level by one or more orders of magnitudes, indicating
that the systems with and without the cannula generated statistically different dissolution
profiles, i.e., that the results obtained with the two systems were unlikely to come from
the some population.
On the other hand, the difference factor f1 and similarity factor f2 for most runs
were within the FDA required ranges, i.e., 0<f1<15 and 50<f2<100, indicating that the
differences introduced by the permanently inserted cannula, although clearly measurable,
were not typically significant enough to fail the dissolution test (although the f1 test for
Position A1 failed). However, the enhancing effect of the presence of the cannula on the
dissolution rate would reduce the tolerance limit of the dissolution test and make the
system with cannula permanently inserted more likely to fail the test. For example, a
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tablet that would intrinsically dissolved slightly faster but still within the dissolution
testing acceptance range if measured in a standard system, could possibly produce an outof-range dissolution profile and fail the test due to the presence of the permanently
inserted cannula enhancing the dissolution rate. Therefore, dissolution test developers
should consider developing baseline dissolution profiles with the cannula always inserted
in order to reduce the impact that any hydrodynamic changes associated with the
presence of the cannula can introduce.
The effect of the presence of the cannula could be observed for both centered and
off-center tablet locations (Table 3.2). On average, this impact was more significant for
tablet closer to the center position. It is important to emphasize the dissolution profiles
for centered tablets were appreciably affected by the presence of the cannula (Figure 3.2),
and this is important in practice because this is the most likely tablet location in most
practical situations. For tablets in the 10° off-center positions, the cannula effect was
even more significant, but only for tablets positioned the nearest to the cannula (Position
A1; Figure 3.3). For the tablets in the 20° off-center positions, a similar but reduced trend
was observed by comparing the dissolution profiles for tablets at the same azimuthal
location nearest to the cannula but at different off-center displacements, i.e., Position A1
(on the 10° circle; Figure 3.3) vs. Position A2 ( on the 20° circle; Figure 3.7).
The reasons for such a small geometric change (the cannula OD was only 3.14
mm and the length immersed in the medium was 44.22 mm) could produce an
appreciable effect on dissolution can be attributed to two different but related
phenomena. The first is the presence of a small “baffle” introduced by the inserted
cannula in the dissolution system. As a small symmetrical unbaffled system, the standard
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USP Apparatus 2 generates a tangential flow with very limited velocity components in
vertical and radial directions around the impeller and the shaft (Bai and Armenante, 2008;
Bai et al., 2011, 2007; Baxter et al., 2005). The tangential flow would be partially
affected by the cannula, just like any small baffle. A slightly stronger top-to-bottom
recirculation could be produced in the system, resulting in the enhanced dissolution rate
of the tables. This is not surprising because a number of mixing literature (Akiti et al.,
2005; Armenante et al., 2005; Atiemo-Obeng et al., 2004) documents the effect of the
introduction of baffles, even small baffles, on mixing.
The second effect is a small asymmetry introduced by the cannula inserted on one
side of an otherwise symmetrical USP Apparatus 2 system. As a perfectly symmetrical
system, Apparatus 2 can be expected to be very sensitive to any deviation from
symmetry, such as the presence of the cannula. In general, asymmetric systems generate a
non-symmetrical three-dimensional flow to enhance mixing effects. Loss of symmetry
can result from a number of geometric irregularities and operating irregularities (Scott,
2005), such as a slightly geometry changes of the vessel (Tanaka et al., 2005; Liddell et
al., 2007), small displacement of the impeller location or even the off-center location of
the tablet (Bai and Armenante, 2009). In most cases, changes in the dissolution profiles
even test failures have typically been reported for these systems.
The combined effects (baffle effect and asymmetry effect) can be especially
important for the flow in the region below the impeller where the tablets are always
located. Usually the flow in this zone is especially week and can be easily perturbed by
even small changes in the system. When this happens, a tablet located in the same region
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can experience a relative but appreciably more intense flow around it, thus resulting in a
relative higher dissolution rate, as observed here for most tablet locations.
The tests conducted using the USP procedure, i.e., the dropping of the tablet in the
vessel at the beginning of the test, confirmed that the cannula had an effect on
dissolution. The dissolution profiles in the testing system were slightly higher than those
in standard system not only when the average of three runs were considered, but also in
each individual run.
As mentioned before, the cannula had a stronger effect on the 10° off-center
locations than on the 20° positions by comparing the tablet position in the same
azimuthal direction but on the different circles. The tablets on the center position were
significantly affected. This implies that the hydrodynamic effect of the cannula is
different depending on the tablet positions, and it is more pronounced when the tablets
are closer to the center of the vessel bottom and in the zone where the cannula was
located (Position A1 and Position A2).

4.2 PIV Measurements
The results of the PIV measurements were consistent with the results from experimental
dissolution tests, and showed that the hydrodynamics in the dissolution vessel was
slightly affected by the introduction of the cannula.
The general, the overall flow pattern in the dissolution vessel was similar in all
four sections in the testing system, according to the velocity vector maps (Figure 3.12 and
Figure 3.13). The main features of this flow consisted of two recirculation loops, below
and above the impeller, and a very weak-velocity region below the shaft. On the other
hand, when the cannula was inserted a significant flow perturbation was observed above
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the impeller, and not only on Section A, i.e., in proximity of the cannula, but also in
Section B and Section C. This confirmed that the cannula produce a “baffle effect”
altering the fluid flow in the vessel. This effect decreased downstream of the cannula and
was minor on Section D, the most downstream section with respect to the cannula
location. The effect of the cannula could be even better noticed by comparing the
velocities on Section A-Front and Section A-Back. The velocity increase in this region is
ultimately responsible for the change in velocities in the lower portion of the vessel and
the resulting increase in the dissolution rate of the tablets fixed in those positions, since
tablets would directly experience the flow in this region.
Further quantitative study on the eleven iso-surfaces selected showed in detail the
differences in the radial velocity profiles and axial velocity profiles between the standard
system and the testing system, and between different sections in the testing system
(Figures 3.14 through 3.19).
In the region above the impeller, the most significant difference was observed in
Section A, and this was in agreement with the observation from the velocity vector maps.
The S values in this region showed the results of the “baffle effect” and the largest S
value was found in Section A. The cannula disturbed the flow in this section and
generated the largest deviation in Section A, and then this flow perturbation extended
downstream through Section B, Section C and became much weaker when passing
through Section D. Much smaller S values were found in Section D, which was in
agreement with the vector velocity map of Section D.
In the region around the impeller, despite the largest variation in the
reproducibility test due to more turbulent flows (Table 3.3), the S values were relative
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uniform in all four sections (Table 3.4), indicating that the introduction of the cannula did
not significantly affect flows in this region, which remained dominated by the impeller.
The region below the impeller was more carefully studied and four iso-surfaces
were selected here (i.e., Z=5 mm, 10 mm, 15 mm and 20 mm), since the dissolution rate
of the tablet was expected to be more sensitive to the flow velocity it experienced directly
in this region. Section A was found to have the largest S value of all the sections, which
coincided with the faster dissolution rates of tablets in Position A1 and Position A2. This
can be explained that the perturbation generated by the cannula above the impeller which
reached the region below the impeller at a location nearest to the cannula. Although the
perturbation may die down along the recirculation pattern, its effect could still be noticed,
especially considering the low velocities baseline below the shaft. This also explained
why the effect was more pronounced for tablets placed 10° off-center circle positions
than 20° off-center circle. The tablet positions in the center and 10° circle were within or
partially within the low velocity region under the impeller, while the 20° circle positions
were within the upwards recirculation region. Therefore, the baseline velocities were
much lower in central and 10° circle positions. As a result, any velocity perturbation in
this region was more significant, and greater differences in dissolution rates between the
two systems were observed for these tablet positions.
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CHAPTER 5
CONCLUSIONS
The hydrodynamic effects of a cannula in USP Dissolution Testing Apparatus 2 were
determined by experimentally comparing the dissolution profiles obtained in the testing
system with those in the standard system, and by determining the flow velocities in the
two systems via PIV.
Several conclusions can be drawn from this study. The cannula inserted in the
USP-specified sampling zone in the USP Apparatus 2 resulted in dissolution profiles for
non-disintegrating salicylic acid tablets located at different positions on the vessel bottom
that were statistically different from the corresponding dissolution profiles obtained in the
absence of the cannula, as indicated by the result of a paired t-test (P(t-test)<0.05). These
differences were reproducible and systematic: in nearly all cases, the presence of the
cannula resulted in faster dissolution rates.
The magnitude of the difference between dissolution profiles depended on tablet
location: larger differences were observed with tablets located closer to the cannula.
These effects can be attributed to the changes in hydrodynamics introduced by the
presence of the cannula, and mainly to the partial to the partial baffling effects and the
loss of symmetry caused by the insertion of the cannula.
The PIV measurements showed that the cannula did have a baffling effect on the
hydrodynamics in the dissolution vessel. This effect resulted in slightly changes in the
velocities in the vessel, and therefore in slightly larger differences in the dissolution rate
of the testing tablets. The baffling effect was clearly observed in the region where the
cannula was inserted. The flow perturbation that it generated became gradually weaker
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downstream of the agitation path. This perturbation was also found to reach the region
below the impeller but only the section nearest to the cannula had significant higher fluid
velocities. Additionally, the PIV results showed that the baffle effect was not strong
enough to break the overall flow pattern, or to affect the region around the impeller,
which was dominated by the agitation flow.
In summary, the hydrodynamic effects generated by the cannula are real and
observable, resulting in slightly modification of the fluid flow in the dissolution vessel
and therefore in detectable differences in the dissolution profiles. Although the
differences between the dissolution profiles in two systems were generally small enough
for the dissolution profiles to be considered acceptable using the FDA criteria (f1 and f2
values), the enhanced dissolution rate caused by the cannula could reduce the tolerance
limit of the dissolution test and make tablets tested in systems with a cannula
permanently inserted more likely to fail the test. Therefore, it is recommended that
dissolution test developers who plan to conduct manual sampling with the cannula
inserted permanently should develop baseline dissolution profiles with a cannula always
inserted, in order to reduce the impact that any hydrodynamic changes associated with the
presence of the cannula can introduce.
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